ASSOCIATION FOR ACCESSIBLE MEDICINES for ASSOCIATION FOR ACCESSIBLE MEDICINES
What was lobbied
5 issue areas, each in the filer's own words, with who lobbied on it and where.
Trade (domestic/foreign) TRD
Free Trade Agreements-Trans Pacific Partnership, Generic medicines
| Lobbyist | Covered position, as disclosed |
|---|---|
| CHRISTOPHER DAVIS | — |
| MELISSA SCHULMAN | — |
Copyright/Patent/Trademark CPT
S.214 - Preserve Access to Affordable Generics Act S.504 - Fair and Immediate Release of Generic Drugs Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| CHRISTOPHER DAVIS | — |
| JASON R MONEY | — |
| MELISSA SCHULMAN | — |
| HEIDI WILSON New | Staff Assistant to Rep. Connie Mack (2009-2010) |
Medicare/Medicaid MMM
FY 2014 Budget, Implementation of Health Care Reform, Medicaid Rebates, Prescription Drug Reimbursement, Medicare Part D Program and Generic DrugsH. Con. Res. 25 - Establishing the budget for the United States Government for fiscal year 2014 and setting forth appropriate budgetary levels for fiscal years 2015 through 2023 H.R. 1588 - Medicare Drug Savings Act of 2013 S.740 - Medicare Drug Savings Act of 2013
| Lobbyist | Covered position, as disclosed |
|---|---|
| CHRISTOPHER DAVIS | — |
| JASON R MONEY | — |
| MELISSA SCHULMAN | — |
| HEIDI WILSON New | Staff Assistant to Rep. Connie Mack (2009-2010) |
Budget/Appropriations BUD
Generic Drug User Fees, Funding for FDA, Funding for the Office of Generic Drugs, FY14 Presidential BudgetH. Con. Res. 25 - Establishing the budget for the United States Government for fiscal year 2014 and setting forth appropriate budgetary levels for fiscal years 2015 through 2023 H.R. 2725 FDA Safety over Sequestration Act S. 1413 FDA User Fee Protection Act HR 2410 Agriculture, Rural Development, Food Drug Administration Appropriations Act 2014 S 1244 Agriculture, Rural Development, Food Drug Administration Appropriations Act 2014
| Lobbyist | Covered position, as disclosed |
|---|---|
| CHRISTOPHER DAVIS | — |
| JASON R MONEY | — |
| MELISSA SCHULMAN | — |
| HEIDI WILSON New | Staff Assisstant to Rep. Connie Mack (2009-2010) |
Pharmacy PHA
FY 2014 Budget, Implementation of Health Care Reform, Implementation of Generic Biologics, Prescription Drug Safety, Counterfeit Drugs/Import Safety/Pedigree, Prescription Drug Shortages, Prescription Drug Importation/Re-Importation, Drug Shortages, Pharmaceutical Drug Compounding, Labeling of Generic DrugsH.R.486 - Stop Tampering of Prescription Pills Act of 2013 H.R.1285 - To amend the Controlled Substances Act to make any substance containing hydrocodone a schedule II drug. H.R. 1919 - Safeguarding America's Pharmaceuticals Act of 2013 H.R.1958 - Gray Market Drug Reform and Transparency Act of 2013 H.R.2186 - VALID Compounding Act of 2013 H.R. 3019 SAFE Compounded Drugs Act H.R. 3089 Compounding Clarity Act of 2013 H.R.3204 Drug Quality and Security Act H. Con. Res. 25 - Establishing the budget for the United States Government for fiscal year 2014 and setting forth appropriate budgetary levels for fiscal years 2015 through 2023 H Res - 161 Expressing the sense of the House of Representatives that the Food and Drug Administration should encourage the use of abuse-deterrent formulations of drugs S.214 - Preserve Access to Affordable Generics Act S.504 - Fair and Immediate Release of Generic Drugs Act S.621 - Safe Prescribing Act of 2013 S 957 - Drug Supply Chain Security Act S 959 - Pharmaceutical Quality, Security, and Accountability Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| CHRISTOPHER DAVIS | — |
| MARK D HENDRICKSON | — |
| JASON R MONEY | — |
| MELISSA SCHULMAN | — |
| CHRISTINE SIMMON | — |
| HEIDI WILSON New | Staff Assistant to Rep. Connie Mack (2009-2010) |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.